Analysis of information received during treatment and adherence to tamoxifen in breast cancer patients
| Autor: | Aline Cruz, Priscila Gava Mazzola, Rebeca Stahlschmidt, Nice Maria Oliveira Silva, Aline Teotonio Rodrigues, Amanda Canato Ferracini |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Socio demographics lcsh:Medicine Disease Teaching hospital 03 medical and health sciences breast cancer 0302 clinical medicine Breast cancer Quality of life Internal medicine medicine Radiology Nuclear Medicine and imaging 030212 general & internal medicine skin and connective tissue diseases Original Paper tamoxifen business.industry lcsh:R Cancer Mean age medicine.disease quality of life Oncology 030220 oncology & carcinogenesis medication adherence business Tamoxifen medicine.drug |
| Zdroj: | Contemporary Oncology Contemporary Oncology, Vol 21, Iss 4, Pp 295-298 (2017) |
| ISSN: | 1428-2526 |
| DOI: | 10.5114/wo.2017.72397 |
| Popis: | This study examines whether women with breast cancer, who are adherent and non-adherent to tamoxifen, differ in their perceptions of information received during treatment. This cross-sectional study included women receiving tamoxifen as adjuvant treatment for breast cancer recruited from a teaching hospital specialised in women’s health in the state of São Paulo (Brazil). Women were interviewed and their records were reviewed for socio demographic data and clinical characteristics. We assessed tamoxifen adherence using the Morisky-Green Test, and the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire – Information module (EORTC QLQ-INFO25) was used to evaluate the information received by the women. The sample contained 31 women (mean age = 55.4; SD = 11.6 years). According to the Morisky-Green Test, 74.2% of the women had suboptimal tamoxifen adherence. The global score for women’s perceptions of information they received about the treatment and disease was 57.0 ±19.1 on a scale of 0 to 100, and no significant differences in scores were observed between adherents and non-adherents. A high prevalence of suboptimal tamoxifen adherence was observed. We found no significant differences between women with breast cancer who were adherent and non-adherent to tamoxifen. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|